Discovery & the sleep-factor story

• How DSIP was discovered and why it was called a "sleep factor"
• The sleep science you need to read its studies critically
• Why its mechanism and even its receptor remain unresolved
• How to separate small historical human data from animal-only claims

1. 01 Discovery & the sleep-factor story The peptide that was named for sleep before anyone could prove it free
2. 02 Sleep science foundations The sleep science you need to read DSIP studies honestly paid
3. 03 Chemistry & stability A simple peptide with a serious durability problem paid
4. 04 How DSIP works Many proposed mechanisms, no confirmed target paid
5. 05 The human sleep evidence What the actual human sleep studies show, and how small they are paid
6. 06 Stress, endocrine & the HPA axis DSIP’s clearest human signal is not about sleep at all paid
7. 07 Beyond sleep: other applications Withdrawal, pain, antioxidants, and the lifespan claim paid
8. 08 DSIP in context & regulatory status How DSIP compares to real sleep medicines, and why it never became one paid
9. 09 Dosing & Administration How DSIP is prepared and discussed, for education only paid
10. 10 Safety & Side Effects What we know about DSIP safety, and the bigger gray-market risk paid
11. 11 Final Exam & Certification Pass the final exam to earn your specialist certificate. Exam

DSIP came out of a strikingly direct idea: if sleep is driven by a chemical signal, you should be able to take it from a sleeping animal and find it. Monnier and Schoenenberger electrically stimulated the sleep-promoting region of rabbit brains, collected the venous blood, and isolated the fraction that enhanced delta-wave activity when given to other rabbits. Four years of purification narrowed it to a single nonapeptide.

DSIP research did not build steadily toward a drug. It surged in the late 1970s and 1980s, branched into stress, pain, and endocrine effects, and then stalled. Tracing the timeline shows how a promising "sleep factor" became a long-running scientific puzzle rather than a medicine.

What stands out is the gap between attention and resolution. Hundreds of papers explored DSIP across sleep, stress, pain, and aging, yet the most basic questions, what its receptor is and whether it is a true hormone, were never answered. By the 2000s, reviews were openly calling it an unresolved riddle.

Strip away the "sleep factor" framing and DSIP is a short, simple chain: nine amino acids in the fixed order Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu, often written WAGGDASGE. It carries no metal, no sugar, and no unusual chemistry. Click each residue below to see what little we can say about its role.

That simplicity is exactly why DSIP is puzzling. There is no obvious binding pocket, no confirmed receptor, and no consensus on whether the body even makes intact DSIP or only fragments that an antibody mistakes for it. Small linear peptides like this are also broken down quickly, which sets up the stability problems covered later in the course.

Before the deeper science, here is the honest picture: what is genuinely supported for DSIP versus what is merely interesting. Almost everything sits lower on this scale than the marketing suggests, and keeping the tiers separate is the single most useful skill this course teaches. The four tiers below run from what is genuinely settled down to what is missing entirely, and the gap between them is the whole point. Read the tier, not just the headline, and most overconfident DSIP claims quietly fall a level or two.

DSIP is sold and discussed online with confident claims. Held against the actual studies, most are not flatly false so much as wildly overstated: a small or animal-only signal rounded up into a guarantee. Tap each claim to see its real evidence tier.

The pattern repeats throughout DSIP’s literature: a real but narrow finding, usually in animals or a tiny human sample, gets stretched into a broad health claim. Learning to ask "in what species, how many subjects, measuring what?" is what separates honest reading from hype.

The most interesting idea in DSIP research is that it may not be a sedative at all. Classic sleeping pills force sedation; DSIP appeared, in some studies, to normalise disturbed sleep without knocking subjects out, and even increased daytime sleep pressure after a morning dose. The two framings make very different predictions.

This distinction matters for the whole course. If DSIP is a normaliser rather than a sedative, then it would only "work" in people whose sleep is already dysregulated, at the right circadian time, which is exactly the kind of effect that small, uncontrolled studies struggle to capture. It also explains why user reports are so contradictory.